Search Results - "Iqbal, Omer M."

Differences in Vascular Access Can Influence the Level of Thrombo-Inflammation and Oxidative Stress in Patients with Hemodialysis: FR-PO496 by Siddiqui, Fakiha, Nikolovski, Srdjan, Kantarcioglu, Bulent, Hoppensteadt, Debra, Iqbal, Omer M., Krupa, Emily G., Fareed, Jawed, Bansal, Vinod K.

Get full text

Dysregulation of Fatty Acid Binding Protein and Their Relationship with Inflammatory Biomarkers in ESRD: PO0875 by Bontekoe, Emily, Bansal, Vinod K., Siddiqui, Fakiha, Iqbal, Omer M., Fareed, Jawed

Get full text

Dysregulation of Fibrinolytic Process Contributes to the Thrombotic and Bleeding Complications in ESRD Patients: PO0945 by Siddiqui, Fakiha, Bansal, Vinod K., Iqbal, Omer M., Bontekoe, Emily, Fareed, Jawed

Get full text

Dysregulation of Fatty Acid Binding Protein and Its Relationship With Inflammatory Biomarkers in Atrial Fibrillation and Renal Dysfunction: TH-PO617 by Bansal, Vinod K., Bontekoe, Emily, Jaradeh, Mark, Allen, Madeline T., Hoppensteadt, Debra, Siddiqui, Fakiha, Iqbal, Omer M., Fareed, Jawed, Syed, Mushabbar

Get full text

Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results by Ghoreishi, Abdoreza, Arsang-Jang, Shahram, Sabaa-Ayoun, Ziad, Yassi, Nawaf, Sylaja, P.N., Akbari, Yama, Divani, Afshin A., Biller, Jose, Phan, Thanh, Steinwender, Sandy, Silver, Brian, Zand, Ramin, Basri, Hamidon Bin, Iqbal, Omer M., Ranta, Annemarei, Ruland, Sean, Macri, Elizabeth, Ma, Henry, Nguyen, Thanh N., Abootalebi, Shahram, Gupta, Animesh, Alet, Matias, Lattanzi, Simona, Desai, Masoom, Gagliardi, Rubens J., Girotra, Tarun, Inoue, Manabu, Yoshimoto, Takeshi, Isaac, Cristian Flavo, Mayer, Stephan A., Morovatdar, Negar, Nilanont, Yongchai, Nobleza, Christa O'Hana S., Saber, Hamidreza, Kamenova, Saltanat, Kondybayeva, Aida, Krupinski, Jerzy, Siegler, James E., Stranges, Saverio, Torbey, Michel T., Yorio, Diana, Zurrú, María Cristina, Rubinos, Clio Aracelli, Shahripour, Reza Bavarsad, Borhani-Haghighi, Afshin, Napoli, Mario Di, Azarpazhooh, M. Reza

“…The emergence of the COVID-19 pandemic has significantly impacted global healthcare systems and this may affect stroke care and outcomes. This study examines…”
Get full text

Metabolic syndrome marker profile in patients with hepatocellular carcinoma HCC by Guler, Nil, Scaglione, Steve, Syed, Daneyal, Martin, Danyelle, Hoppensteadt, Debra, Saluk, Jennifer, Sandhu, Jasmin, Palumbo, Rachel, Layden, Thomas, Iqbal, Omer M., Fareed, Jawed

“…Abstract only…”
Get full text

Benign cystic ovarian neoplasms and procoagulant potential by Iqbal, Omer M., Ersahin, Cagatay, Hu, Zhihong, Duan, Xiuzhen, Hoppensteadt, Debra

“…Abstract only e15538 Background: Ovarian cancer is one of the leading causes of increased morbidity and mortality worldwide. The fluid content of the cystic…”
Get full text

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism by Phan, Trung, Brailovsky, Yevgeniy, Fareed, Jawed, Hoppensteadt, Debra, Iqbal, Omer, Darki, Amir

“…The aim of this study was to investigate the utility of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) to predict all-cause…”
Get full text

Ultrasound Accelerated Catheter Directed Thrombolytic Therapy in a 15-Year-old Pulmonary Embolism Patient with CLOVES Syndrome by Abourahma, Mohammed, Mohammed, Wajahat, Kantarcioglu, Bulent, Laddu, Atul, Iqbal, Omer

Get full text

Decreased Thrombin Generation is Associated with Increased Thrombin Generation Biomarkers and Blood Cellular Indices in Pulmonary Embolism by Siddiqui, Fakiha, Tafur, Alfonso, Darki, Amir, Kantarcioglu, Bulent, Hoppensteadt, Debra, Krupa, Emily, Iqbal, Omer, Fareed, Jawed, Monreal, Manuel

“…Pulmonary embolism (PE) is a heterogenous condition with variable clinical presentations. Thrombin generation potential (TGP) and biomarkers, and blood…”
Get full text

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa by Lewis, Joseph, Iqbal, Omer, Jeske, Walter, Hoppensteadt, Debra, Siddiqui, Fakiha, Fareed, Jawed

“…Introduction Andexanet alfa (andexanet) is an approved antidote used to reverse the bleeding effects of Direct Oral Anticoagulant (Direct-Xa agents) agents…”
Get full text

Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin by Olson, Guy, Jeske, Walter, Iqbal, Omer, Krupa, Emily, Farooqui, Amber, Siddiqui, Fakiha, Hoppensteadt, Debra, Kouta, Ahmed, Fareed, Jawed

“…Introduction: Bovine and ovine mucosa represent alternate anticoagulants to porcine mucosa for production of unfractionated heparin (UFH). Standardized…”
Get full text

Upregulation of Inflammatory Cytokines in Pulmonary Embolism Using Biochip-Array Profiling by Bontekoe, Emily, Brailovsky, Yevgeniy, Hoppensteadt, Debra, Bontekoe, Jack, Siddiqui, Fakiha, Newman, Joshua, Iqbal, Omer, Reed, Trent, Fareed, Jawed, Darki, Amir

“…The complex pathophysiology of pulmonary embolism (PE) involves hemostatic activation, inflammatory processes, cellular dysfunction, and hemodynamic…”
Get full text

An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination by Kantarcioglu, Bulent, Iqbal, Omer, Walenga, Jeanine M., Lewis, Bruce, Lewis, Joseph, Carter, Charles A., Singh, Meharvan, Lievano, Fabio, Tafur, Alfonso, Ramacciotti, Eduardo, Gerotziafas, Grigoris T., Jeske, Walter, Fareed, Jawed

“…Today the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a global health problem…”
Get full text

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations by Kantarcioglu, Bulent, Iqbal, Omer, Lewis, Joseph, Carter, Charles A., Singh, Meharvan, Lievano, Fabio, Ligocki, Mark, Jeske, Walter, Adiguzel, Cafer, Gerotziafas, Grigoris T., Fareed, Jawed

“…The progress in the development of various vaccine platforms against SARS-CoV-2 have been rather remarkable owing to advancement in molecular and biologic…”
Get full text

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa by Siddiqui, Fakiha, Tafur, Alfonso, Bontekoe, Emily, Iqbal, Omer, Jeske, Walter, Mehrotra, Siddharth, Hoppensteadt, Debra, Ramacciotti, Eduardo, Fareed, Jawed

“…Andexanet alfa is a recombinant factor Xa decoy protein, designed to reverse bleeding associated with oral anti-Xa agents. Andexanet alfa is also reported to…”
Get full text

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values by Siddiqui, Fakiha, Tafur, Alfonso, Ramacciotti, Lorenzo Storino, Jeske, Walter, Hoppensteadt, Debra, Ramacciotti, Eduardo, Iqbal, Omer, Fareed, Jawed

“…Recombinant coagulation factor Xa (FXa), inactivated Zh-zo, also known as andexanet alfa (AA), is a modified version of human FXa that has been developed to…”
Get full text

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum by Siddiqui, Fakiha, Hoppensteadt, Debra, Jeske, Walter, Iqbal, Omer, Tafur, Alfonso, Fareed, Jawed

“…The currently available oral anti-Xa agents are claimed to produce their anticoagulant and antithrombotic effects solely by the inhibition of factor Xa. This…”
Get full text

Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey by Kantarcioglu, Bulent, Patel, Krishan, Lewis, Joseph, Iqbal, Omer, Siddiqui, Fakiha, Jabeen, Nusrat, Laddu, Atul R., Carter, Charles A., Fareed, Jawed

“…Introduction We conducted a cross-sectional survey as a part of an educational program in collaboration with the Global Thrombosis Forum (GTF), an affiliate of…”
Get full text

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis by Mehrotra, Siddharth, Hoppensteadt, Debra, Jeske, Walter, Siddiqui, Fakiha, Iqbal, Omer, Tafur, Alfonso, Lewis, Bruce, Jaradeh, Mark, Kantarcioglu, Bulent, Fareed, Jawed

“…Introduction The available oral anti-Xa agents are routinely used for the management of thrombotic disorders. A molecularly modified recombinant coagulation…”
Get full text